Share to:

CJC 1295 with DAC 5mg

CJC 1295 With DAC is a synthetic peptide hormone with a half-life of 6-8 days. It promotes cell growth and repair, accelerates wound healing, and aids muscle repair and regeneration in sports medicine, shortening recovery time. It addresses growth hormone deficiency by improving growth retardation, promoting height growth in children and adolescents, and enhancing the quality of life in adults while optimizing body composition with increased muscle mass and reduced body fat. It offers a new solution for growth hormone-related issues and may improve aging-related symptoms in individuals with decreased growth hormone secretion due to aging, such as increasing bone density, enhancing muscle strength, and improving skin elasticity. Compared to traditional treatments, its unique DAC binding allows a single dose to stimulate growth hormone secretion for several days, reducing dosing frequency and improving patient compliance. With good safety and tolerability profiles and few adverse reactions, it has a solid foundation for clinical application and promotion.

The peptide will be provided as lyophilized powder to ensure maximum stability.

Price:

$130.00

1kits(10Vials)

product Description:

What is CJC1295 With DAC ?

CJC 1295 With DAC is a medically significant synthetic peptide hormone. It comprises the 30 – amino – acid CJC 1295 peptide combined with a Drug Affinity Complex (DAC), enhancing stability and bioavailability and extending its half – life to 6 – 8 days.

 

It’s highly valued in life sciences and related fields. It promotes cell growth and repair, speeds up wound healing, aids muscle repair and regeneration in sports medicine, shortening recovery. In growth hormone deficiency treatment, it improves growth retardation, promotes height growth in young people, enhances adults’ quality of life, and optimizes body composition with more muscle and less fat.

 

CJC 1295 With DAC offers new solutions for growth – hormone – related issues. For those with reduced growth hormone secretion due to aging, it may improve aging – related symptoms like increased bone density, enhanced muscle strength, and improved skin elasticity.

 

Compared to traditional growth hormone treatments, CJC 1295 With DAC has advantages. Its unique DAC binding enables a single dose to stimulate growth hormone secretion for days, reducing dosing frequency and improving patient compliance. Also, it has good safety and tolerability with few adverse reactions.

 

CJC1295 With DAC Research

What is the research background of CJC1295 With DAC?

The application of traditional growth hormone-releasing hormone (GHRH) in treatment is limited by its short duration of action. This has prompted researchers to seek more long-acting growth hormone-releasing hormone analogs to improve treatment efficacy and convenience. With people’s pursuit of health and beauty, public online folk pharmacology has provided the impetus for shortcuts to achieve muscle enhancement, fat reduction, and youthful skin. Against this backdrop, synthetic growth hormone analogs such as CJC1295 With DAC have attracted attention. Research shows that forum users demonstrate proficiency and experience in its multi-purpose use, and the purposes for choosing to use such substances include weight loss, muscle enhancement, skin rejuvenation, improved sleep, and wound healing, etc[1]. As a long-acting growth hormone-releasing hormone analog, the development of CJC1295 With DAC is based on an in-depth understanding of the regulatory mechanism of growth hormone. Although most children with isolated growth hormone (GH) deficiency have a good growth response to GHRH, the half-life of GHRH is extremely short, limiting its therapeutic effect. To address this issue, researchers have developed CJC1295 With DAC, a long-acting GHRH analog. Studies have shown that it incorporates a functional maleimide group at the C-terminus, allowing it to covalently bind to plasma proteins such as serum albumin, thereby increasing its half-life and being able to stimulate growth hormone production in humans for more than six days after a single administration [2]

Related Product:

error: Content is protected !!